23andMe can now test for BRCA mutations for Breast Cancer

0
582

There’s only so much the test can actually tell you about breast cancer.

The Food & Drug Administration is finally allowing 23andMe to provide testing for the breast cancer-related genes BRCA1 and 2. Back in 2013, when the direct-to-consumer company originally starting selling the test, the FDA clamped down and forced 23andMe to verify its genetic health risk evaluations. 23andMe had to prove the genes they were testing for were related to a health condition, and show that the tests were accurate.

CONTINUE READING

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Captcha loading...